LifeWave Biomedical — Stock, Pipeline & Market Cap

Is this your company? Claim your profile to update info and connect with investors.

Private Company

Funding information not available

Overview

LifeWave Biomedical is a private, pre-revenue medical technology company based in San Diego, founded in 2018. It is developing an integrated system combining a non-invasive, UWB radar-based device for lung fluid measurement with an agentic AI platform to guide personalized heart failure care and GDMT optimization. The company is targeting the massive economic burden of heart failure hospitalizations with a scalable, value-based care solution and is currently raising a Series B financing round.

Cardiovascular DiseaseHeart Failure

Technology Platform

Proprietary medical radar using Ultra-Wideband (UWB) RF energy for non-invasive physiologic assessment, specifically for direct lung fluid measurement, integrated with an agentic AI software platform for personalized care coordination and GDMT optimization.

Opportunities

The massive and growing economic burden of heart failure hospitalizations ($30B+ in the U.S.) creates a compelling value proposition for a solution proven to reduce admissions.

The shift to value-based care and remote patient monitoring provides a favorable reimbursement environment for a scalable SaaS platform that lowers total cost of care.

Risk Factors

The company faces significant regulatory risk pending FDA clearance of its investigational device and clinical risk in proving its system reduces hospitalizations.

As a pre-revenue company, it is dependent on raising capital (Series B), and faces adoption challenges in integrating a new technology into established clinical workflows.

Competitive Landscape

LifeWave competes with other remote monitoring solutions for heart failure, including implantable devices like Abbott's CardioMEMS (measures pulmonary artery pressure) and non-invasive alternatives from traditional medtech and digital health companies. Its differentiation lies in the combination of a direct, non-invasive lung fluid biomarker with an integrated, AI-driven care management platform.

More companies in Diagnostics & Precision Medicine →More companies in United States →